Preinvasive adenocarcinoma lesion of the lung

Changed by Brian Gilcrease-Garcia, 11 Aug 2018

Updates to Article Attributes

Body was changed:

Preinvasive lesions for lung adenocarcinoma are a typecategory of small noninvasive lung lesion which are closely related to adenocarcinoma of the lung. They may represent a spectrum of premalignant andto low-grade malignant lesions.

The category includes two types of lesions:

Terminology

In 2011, the International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS), and European Respiratory Society (ERS) introduced a new classification and terminology for adenocarcinoma of the lung.  In addition to retiring the term "bronchoalveolar carcinoma (BAC)", the 2011 update officially recognized "adenocarinoma in situ" as a distinct entity with excellent clinical prognosis.

Given its relatively recent recognition, adenocarcinoma in situ remains somewhat controversial and is variable regarded as a low-grade malignancy.

Pathology

Atypical adenomatous hyperplasia and adenocarcinoma in situ may be considered a spectrum of premalignant disease, where atypical adenomatous hyperplasia is typically a small (<5≤5 mm) lesion with mild-moderate cellular atypia, while adenocarcinoma in situ lesions are larger, butyet still ≤3 cm and without evidence ofdemonstrating purely lepidic growth (no invasion). Indeed, intermediate cases may be difficult to distinguish 1.

Findings which indicate more advancedprofound genetic alteration, such as non-lepidic (e.g. papillary) growth patterns or tumor necrosis, indicateindicatemore advanced grade of disease.

Radiographic features

Preinvasive lesions of adenocarcinoma are generally not evident by x-ray.

On CT, both atypical adenomatous hyperplasia and adenocarcinoma in situ typically manifest as a higherround, purely ground glass opacity.

  • usually a single opacity 2
    • multiple lesions more common with AIS 2
  • "clear" periphery (>85%) 2
    • lobuation, spiculation, pleural indentation are seen in both AAH and AIS, but less common (<21%)
  • vacuole sign - internal gas-appearing lucency <5 mm
    • specific to AIS in one 2017 radiology/pathology correlative study (n=80 lesions) 2
  • -<p><strong>Preinvasive lesions for lung adenocarcinoma</strong> are a type of small noninvasive lung lesion which are closely related to adenocarcinoma of the lung. They may represent a spectrum of premalignant and low-grade malignant lesions.</p><p>The category includes two types of lesions:</p><ul>
  • +<p><strong>Preinvasive lesions for lung adenocarcinoma</strong> are a category of small noninvasive lung lesion which are closely related to <a href="/articles/adenocarcinoma-of-the-lung">adenocarcinoma of the lung</a>. They may represent a spectrum of premalignant to low-grade malignant lesions.</p><p>The category includes two types of lesions:</p><ul>
  • -<a title="Atypical adenomatous hyperplasia (AAH)" href="/articles/atypical-adenomatous-hyperplasia-of-the-lung">atypical adenomatous hyperplasia (AAH)</a> - smaller, mild-moderate cellular atypia</li>
  • +<a href="/articles/atypical-adenomatous-hyperplasia-of-the-lung">atypical adenomatous hyperplasia (AAH)</a> - smaller, mild-moderate cellular atypia, without evidence of invasion</li>
  • -<a title="Adenocarcinoma in situ (AIS) of lung" href="/articles/adenocarcinoma-in-situ-of-the-lung">adenocarcinoma in situ (AIS)</a> - larger and with more atypia, although no evidence of invasion</li>
  • -</ul><h4>Terminology</h4><p>In 2011, the International Association for the Study of Lung Cancer (IASLC), American Thoracic Society (ATS), and European Respiratory Society (ERS) introduced a new classification and terminology for adenocarcinoma of the lung.  In addition to retiring the term "bronchoalveolar carcinoma (BAC)", the 2011 update officially recognized "adenocarinoma in situ" as a distinct entity with excellent clinical prognosis. </p><p>Given its relatively recent recognition, adenocarcinoma in situ remains somewhat controversial and is variable regarded as a low-grade malignancy.</p><h4>Pathology</h4><p>Atypical adenomatous hyperplasia and adenocarcinoma in situ may be considered a spectrum of premalignant disease, where atypical adenomatous hyperplasia is typically a small (&lt;5 mm) lesion with mild-moderate cellular atypia, while adenocarcinoma in situ lesions are larger, but still ≤3 cm and without evidence of invasion. Indeed, intermediate cases may be difficult to distinguish <sup>1</sup>.</p><p>Findings which indicate more advanced genetic alteration, such as non-lepidic (e.g. papillary) growth patterns or tumor necrosis, indicate a higher</p>
  • +<a href="/articles/adenocarcinoma-in-situ-of-the-lung">adenocarcinoma in situ (AIS)</a> - larger and with more atypia, although still without evidence of invasion</li>
  • +</ul><h4>Terminology</h4><p>In 2011, the International Association for the Study of Lung Cancer, American Thoracic Society, and European Respiratory Society introduced a new classification and terminology for adenocarcinoma of the lung.  In addition to retiring the term "bronchoalveolar carcinoma (BAC)", the 2011 update officially recognized "adenocarinoma in situ" as a distinct entity with excellent clinical prognosis.</p><h4>Pathology</h4><p>Atypical adenomatous hyperplasia and adenocarcinoma in situ may be considered a spectrum of premalignant disease, where atypical adenomatous hyperplasia is typically a small (≤5 mm) lesion with mild-moderate cellular atypia, while adenocarcinoma in situ lesions are larger, yet still ≤3 cm and demonstrating purely lepidic growth (no invasion). Indeed, intermediate cases may be difficult to distinguish <sup>1</sup>.</p><p>Findings which indicate more profound genetic alteration, such as non-lepidic (e.g. papillary) growth patterns or tumor necrosis, indicatemore advanced grade of disease.</p><h4>Radiographic features</h4><p>Preinvasive lesions of adenocarcinoma are generally not evident by x-ray.</p><p>On CT, both atypical adenomatous hyperplasia and adenocarcinoma in situ typically manifest as a round, purely ground glass opacity.</p><ul>
  • +<li>usually a single opacity <sup>2</sup><ul><li>multiple lesions more common with AIS <sup>2</sup>
  • +</li></ul>
  • +</li>
  • +<li>"clear" periphery (&gt;85%) <sup>2</sup><ul><li>lobuation, spiculation, pleural indentation are seen in both AAH and AIS, but less common (&lt;21%)</li></ul>
  • +</li>
  • +<li>vacuole sign - internal gas-appearing lucency &lt;5 mm<ul><li>specific to AIS in one 2017 radiology/pathology correlative study (n=80 lesions) <sup>2</sup>
  • +</li></ul>
  • +</li>
  • +</ul>

References changed:

  • 1. Travis WD, Brambilla E, Noguchi M et-al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol. 2011;6 (2): 244-85. <a href="http://dx.doi.org/10.1097/JTO.0b013e318206a221">doi:10.1097/JTO.0b013e318206a221</a> - <a href="http://www.ncbi.nlm.nih.gov/pubmed/21252716">Pubmed citation</a><span class="ref_v3"></span>
  • 2. Pan X, Yang X, Li J, Dong X, He J, Guan Y. Is a 5-mm diameter an appropriate cut-off value for the diagnosis of atypical adenomatous hyperplasia and adenocarcinoma in situ on chest computed tomography and pathological examination?. (2018) Journal of thoracic disease. 10 (Suppl 7): S790-S796. <a href="https://doi.org/10.21037/jtd.2017.12.124">doi:10.21037/jtd.2017.12.124</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/29780625">Pubmed</a> <span class="ref_v4"></span>

Tags changed:

  • cases
  • refs

Sections changed:

  • Classifications

Systems changed:

  • Chest
  • Oncology

Updates to Synonym Attributes

Updates to Synonym Attributes

Updates to Synonym Attributes

Updates to Synonym Attributes

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.